KAVEH KOUSARI
Allopathic & Osteopathic Physicians|Urology PENNINGTON, NJ NPI 1407083199
Browse related groups: Allopathic & Osteopathic Physicians|Urology NJ Astellas Pharma US Inc All categories
General Payments — all program years on this page
$2,641.11
- Category: General Payments
- Program years: PY2018–2024
- Record count: 118
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $159.14 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $159.14 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $40.90 | 2 |
| Sumitomo Pharma America, Inc. | $33.59 | 2 |
| Medtronic, Inc. | $31.63 | 1 |
| Myriad Genetic Laboratories, Inc. | $18.91 | 1 |
| PFIZER INC. | $17.38 | 1 |
| Calyxo, Inc. | $16.73 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1099417842 | Calyxo, Inc. | $16.73 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119303790 | Medtronic, Inc. | $31.63 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131299215 | PFIZER INC. | $17.38 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139301242 | Astellas Pharma US Inc | $20.39 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139318448 | Astellas Pharma US Inc | $20.51 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148876632 | Sumitomo Pharma America, Inc. | $16.97 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148876634 | Sumitomo Pharma America, Inc. | $16.62 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1152534240 | Myriad Genetic Laboratories, Inc. | $18.91 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.